Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report.
- Published in:
- Journal of Ovarian Research, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13048-020-00751-3
- By:
- Publication type:
- Article